Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v18-EN Version v8-EN
Language English English
Date Updated 2018-08-29 2018-03-14
Drug Identification Number 02218488 02218488
Brand name MERREM MERREM
Common or Proper name Meropenem meropenem
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients MEROPENEM MEROPENEM
Strength(s) 500MG 500MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 20 mL vial 20 mL vial
ATC code J01DH J01DH
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2017-10-09
Actual start date 2017-10-10 2017-10-10
Estimated end date 2018-03-26
Actual end date 2018-08-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product has been discontinued. Update to import licence required
Health Canada comments